We further studied the therapeutic effects of sPIF on mdx mice that represent a pre-clinical model of DMD and have a premature stop codon mutation on exon 23 of the dystrophin gene, which results in a lack of the mature protein. This evidence concerns the gene DMD and Duchenne muscular dystrophy.